Evidence map›Paper›PMID 23593356›Full record

ArticlePloS one2013

Latent microsporidiosis caused by Encephalitozoon cuniculi in immunocompetent hosts: a murine model demonstrating the ineffectiveness of the immune system and treatment with albendazole.

Michaela Kotkova, Bohumil Sak, Dana Kvetonova, Martin Kvac

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular Prevalence of Microsporidia Infection in Patients with Lung Cancer.The American journal of tropical medicine and hygiene · 2023
    Article
  5. Review
  6. Comparison of the Concentration ofJournal of inflammation research · 2022
    Article
  7. Chronic Infections in Mammals Due to Microsporidia.Experientia supplementum (2012) · 2022
    Article
  8. Immune Response to Microsporidia.Experientia supplementum (2012) · 2022
    Article
  9. Sparse Evidence forPathogens (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Journal of inflammation research · 2020
    Article
  15. Article
  16. Prevention and treatment ofIranian journal of veterinary research · 2016
    Article
  17. Microsporidiosis in Vertebrate Companion Exotic Animals.Journal of fungi (Basel, Switzerland) · 2015
    Review
  18. Article
  19. Microsporidia-host interactions.Current opinion in microbiology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michaela KotkovaInstitute of Parasitology, Biology Centre of Academy of Sciences of Czech Republic, v.v.i., Ceské Budejovice, Czech Republic.
Bohumil Sak
Dana Kvetonova
Martin Kvac
Institute of Parasitology · CZCzech Academy of Sciences, Biology Centre · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicrosporidia are obligate intracellular parasites causing severe infections with lethal outcome in immunocompromised hosts. However, these pathogens are more frequently reported as latent infections in immunocompetent individuals and raises questions about the potential risk of reactivation following induced immunosuppression.

aimsTo evaluate the possibility latent microsporidiosis, efficacy or albendazole, and reactivation, the authors monitored the course of E. cuniculi infection in immunocompetent BALB/c mice and immunodeficient SCID mice using molecular methods.

methodsMice were per orally infected with 10(7) spores of E. cuniculi. Selected groups were treated with albendazole, re-infected or chemically immunosuppressed by dexamethasone. The presence of microsporidia in the host's organs and feces were determined using PCR methods. Changes in numbers of lymphocytes in blood and in spleen after induction of immunosuppression were confirmed using flow cytometry analysis.

resultsWhereas E. cuniculi caused lethal microsporidiosis in SCID mice, the infection in BABL/c mice remained asymptomatic despite parasite dissemination into many organs during the acute infection phase. Albendazole treatment led to microsporidia elimination from organs in BALB/c mice. In SCID mice, however, only a temporary reduction in number of affected organs was observed and infection re-established post-treatment. Dexamethasone treatment resulted in a chronic microsporidia infection disseminating into most organs in BALB/c mice. Although the presence of E. cuniculi in organs of albendazole- treated mice was undetectable by PCR, it was striking that infection was reactivated by immunosuppression treatment.

conclusionOur results demonstrated that microsporidia can successfully survive in organs of immunocompetent hosts and are able to reactivate from undetectable levels and spread within these hosts after induction of immunosuppression. These findings stress the danger of latent microsporidiosis as a life-threatening risk factor especially for individuals undergoing chemotherapy and in transplant recipients of organs originating from infected donors.

Indexed as

Disease Models, AnimalEncephalitozoon cuniculiAlbendazoleAnimalsChlorocebus aethiopsDexamethasoneEncephalitozoonosisFecesFlow CytometryLymphocyte CountMiceMice, Inbred BALB CMice, SCIDPolymerase Chain ReactionVero CellsVisceraAlbendazoleDexamethasone

Identifiers

PMID23593356
PMCPMC3623998
OpenAlexW2032816314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.